Bubs share price storms higher on new China plans

The Bubs Australia Ltd (ASX:BUB) share price is storming higher after announcing its new plan to gain entry into the massive China market…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Bubs Australia Ltd (ASX: BUB) share price is pushing higher on Monday after the release of an update.

At the time of writing the infant formula and baby food company's shares are up almost 4% to 96 cents.

What did Bubs announce?

Investors have been buying Bubs shares this morning after it announced a memorandum of understanding (MOU) with joint venture partner Beingmate.

According to the release, the MOU gives Bubs the opportunity to acquire an ownership interest in one of Beingmate's infant formula manufacturing facilities in Beihai China and obtain Beingmate's support in securing a State Administration for Market Regulation (SAMR) brand slot.

The ultimate objective of this will be producing Bubs China label goat milk infant formula at one of Beingmate's registered facilities with 100% Bubs Australian goat milk.

The company advised that a finished SAMR approved China label product, tailored to the Chinese market, will be sold by Bubs to the Beingmate joint venture company – Bubs Brand Management Shanghai.

The joint venture company, of which Bubs owns a 49% interest, will continue to distribute the Bubs China label product into China's general trade channel, under the terms of the existing agreement.

SAMR difficulties.

The company appears to believe this is the best chance that it will have of joining A2 Milk Company Ltd (ASX: A2M) in the China market.

It notes that since April 2019, 92 product applications have been successful in obtaining SAMR registration. Of these, 77 are manufactured in China.

The remaining 15 products that are manufactured outside of China, 9 are Chinese owned brands manufactured in France. The only international brand to achieve certification during this period was Wyeth for 6 products that are manufactured in Singapore.

Beingmate currently has 51 infant formula products under 17 brands successfully registered by SAMR and being sold nationwide in China.

In light of this, Bubs intends to withdraw its existing SAMR brand applications previously made by Deloraine, and resubmit differentiated super-premium formulations targeting consumers in tier-one cities.

Invaluable support.

Bubs Founder and CEO, Kristy Carr, commented: "We are highly confident this step up in our collaboration with Beingmate, one of the largest Chinese owned enterprises in China's Infant Nutrition industry, who is also our Joint Venture distribution partner, coupled with their extensive capability to manufacture locally in China, will provide invaluable support in securing our SAMR brand registration.This will ultimately provide Bubs with a faster route-to-market and full access into China's Mother and Baby stores."

"Given the current geo-political landscape and regulatory risks, this breakthrough localisation strategy for a 'Created by Bubs' product to be packed in China exclusively from our own Australian premium goat milk mitigates key risks and provides a secure pathway to gaining full access to the world's largest and fastest growing Infant Formula market, valued at A$55 billion," she added.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of BUBS AUST FPO. The Motley Fool Australia owns shares of A2 Milk. The Motley Fool Australia has recommended BUBS AUST FPO. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
Share Gainers

Why Avita Medical, GenusPlus, Mesoblast, and Polynovo shares are storming higher

These shares are having a better day than most today. But why?

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why EOS, News Corp, Polynovo, and Pro Medicus shares are roaring higher today

These shares are starting the week positively. But why?

Read more »

Five young people sit in a row having fun and interacting with their mobile phones.
Share Gainers

5 ASX 200 stocks marching higher this week even as the market sinks

These five ASX 200 companies are shrugging off the broader selling to march higher this week.

Read more »

Rising share price chart.
Share Gainers

Why Novonix, HMC, Karoon Energy, and Ventia shares are pushing higher

These shares are ending the week on a positive note. But why?

Read more »

A young woman smiles as she rides a zip line high above the trees.
Share Gainers

3 top ASX 200 stocks I wish I'd owned in 2024

These three top ASX 200 stocks are racing higher in 2024.

Read more »

Man pointing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why Champion Iron, EBR Systems, Mesoblast, and Patriot Battery Metals shares are surging today

These shares are avoiding the market selloff on Thursday. But why?

Read more »

A man looking at his laptop and thinking.
Share Gainers

Here are the top 10 ASX 200 shares today

Investors ended up snatching defeat from the jaws of victory today.

Read more »

Excited group of friends sitting on sofa watching sports on TV and celebrating.
Share Gainers

Why Clarity, Omni Bridgeway, Santana Minerals, and Vulcan shares are pushing higher today

These shares are having a good time on hump day. But why?

Read more »